Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the safety and efficacy of intravenous cidofovir in patients with
small peripheral cytomegalovirus retinitis.
II. Obtain safety and efficacy data related to different dosages of cidofovir.